Additional Information
Market: NASDAQ
Sector: Food Retailers & Wholesalers
EPIC: CVGW
Latest Price: 27.96  (2.38% Ascending)
52-week High: 28.53
52-week Low: 18.29
Market Cap: 412.95M
1 year chart
1 day chart
Calavo Growers
www.calavo.com

Calavo Growers procures and markets avocados and other perishable commodities, and prepares and distributes processed avocado products.

Avocado Supplier Calavo Growers Posts Record Third Quarter Profits

1st Sep 2010, 4:14 pm
Avocado Supplier Calavo Growers Posts Record Third Quarter Profits

Calavo Growers (“Calavo”) (Nasdaq: CVGW), a supplier and marketer of avocados and other perishable foods based in California, reported that it posted an all-time high for third quarter profits and revenues. 


During the quarter, revenues and profits increased 8% and 141%, respectively, thanks to higher avocado sales and growth in the fresh produce segment.  


For the quarter ended July 31, 2010, Calavo recorded profits of $5.9 million, or $0.41 per diluted share, on revenues of $114.6 million compared to $2.5 million, or $0.17 per diluted share, on revenues of $106.3 million for the same period the previous year. 


The Fresh Product segment totalled $100.7 million for the third quarter, a 6% increase from a year before.  Unit sales increased 43% for the segment thanks to a 47% year-over-year increase in avocado sales. 


The growth in avocado sales is likely to be sustainable because of rising demand due to industry promotion and awareness of the fruit’s health benefits, the company said. 


Looking forward, Lee E. Cole, the CEO of Calavo, said, "From all indications, the fresh avocado harvest will continue to be substantial, with a total estimated supply of around 1.3 billion pounds, propelled by an abundant California supply and augmented by our other established sources in Mexico and Chile.”


Volume growth in prepared avocado products helped the Calavo Foods business segment to increase revenues by 20% on a year-over-year basis during the third quarter.  Revenues for the segment totalled $13.9 million.  


The market was nonetheless indifferent to the Calavo’s results; the company’s share price dropped 1.2% to trade at $19.39.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.